-
1
-
-
33846515640
-
Myelodysplastic syndromes: The complexity of stem-cell diseases
-
Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer. 2007; 7: 118-129
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 118-129
-
-
Corey, S.J.1
Minden, M.D.2
Barber, D.L.3
Kantarjian, H.4
Wang, J.C.5
Schimmer, A.D.6
-
2
-
-
84868201807
-
Molecular genetics in myelodysplastic syndromes
-
Haferlach T. Molecular genetics in myelodysplastic syndromes. Leuk Res. 2012; 36: 1459-1462
-
(2012)
Leuk Res
, vol.36
, pp. 1459-1462
-
-
Haferlach, T.1
-
3
-
-
84860389167
-
Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study
-
de Hollanda A, Beucher A, Henrion D, Ghali A, Lavigne C, Levesque H, et al. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res. 2011; 63: 1188-1194
-
(2011)
Arthritis Care Res
, vol.63
, pp. 1188-1194
-
-
De Hollanda, A.1
Beucher, A.2
Henrion, D.3
Ghali, A.4
Lavigne, C.5
Levesque, H.6
-
4
-
-
84892967412
-
Inflammatory arthritis in patients with myelodysplastic syndromes: A multicenter retrospective study and literature review of 68 cases
-
Mekinian A, Braun T, Decaux O, Falgarone G, Toussirot E, Raffray L, et al. Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases. Medicine. 2014; 93: 1-10
-
(2014)
Medicine
, vol.93
, pp. 1-10
-
-
Mekinian, A.1
Braun, T.2
Decaux, O.3
Falgarone, G.4
Toussirot, E.5
Raffray, L.6
-
5
-
-
17344372458
-
Association between myelodysplastic syndromes and inflammatory bowel diseases report of seven new cases and review of the literature
-
Hebbar M, Kozlowski D, Wattel E, Mastrini S, Dievart M, Duclos B, et al. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia. 1997; 11: 2188-2191
-
(1997)
Leukemia
, vol.11
, pp. 2188-2191
-
-
Hebbar, M.1
Kozlowski, D.2
Wattel, E.3
Mastrini, S.4
Dievart, M.5
Duclos, B.6
-
6
-
-
44449119097
-
Concurrent inflammatory bowel disease and myelodysplastic syndrome: Report of nine new cases and a review of the literature
-
Wang Z, Zhou Y, Liu Y. Concurrent inflammatory bowel disease and myelodysplastic syndrome: report of nine new cases and a review of the literature. Digest Dis Sci. 2008; 53: 1929-1932
-
(2008)
Digest Dis Sci
, vol.53
, pp. 1929-1932
-
-
Wang, Z.1
Zhou, Y.2
Liu, Y.3
-
7
-
-
65449178870
-
Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells
-
Nakamura F, Watanabe T, Hori K, Ohara Y, Yamashita K, Tsuji Y, et al. Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells. Digestion. 2009; 79: 215-219
-
(2009)
Digestion
, vol.79
, pp. 215-219
-
-
Nakamura, F.1
Watanabe, T.2
Hori, K.3
Ohara, Y.4
Yamashita, K.5
Tsuji, Y.6
-
8
-
-
84879779773
-
Myelodysplastic syndromes and autoimmune diseases-case series and review of literature
-
Al Ustwani O, Ford LA, Sait SJ, Block AM, Barcos M, Vigil CE, et al. Myelodysplastic syndromes and autoimmune diseases-case series and review of literature. Leuk Res. 2013; 37: 894-899
-
(2013)
Leuk Res
, vol.37
, pp. 894-899
-
-
Al Ustwani, O.1
Ford, L.A.2
Sait, S.J.3
Block, A.M.4
Barcos, M.5
Vigil, C.E.6
-
9
-
-
37349079211
-
Vasculitides associated with malignancies: Analysis of sixty patients
-
Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Paries J, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007; 57: 1473-1480
-
(2007)
Arthritis Rheum
, vol.57
, pp. 1473-1480
-
-
Fain, O.1
Hamidou, M.2
Cacoub, P.3
Godeau, B.4
Wechsler, B.5
Paries, J.6
-
11
-
-
61749100610
-
Risks of myeloid malignancies in patients with autoimmune conditions
-
Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009; 100: 822-828
-
(2009)
Br J Cancer
, vol.100
, pp. 822-828
-
-
Anderson, L.A.1
Pfeiffer, R.M.2
Landgren, O.3
Gadalla, S.4
Berndt, S.I.5
Engels, E.A.6
-
12
-
-
79952787641
-
Increased cancer risks among arthroplasty patients: 30 year follow-up of the swedish knee arthroplasty register
-
Wagner P, Olsson H, Lidgren L, Robertsson O, Ranstam J. Increased cancer risks among arthroplasty patients: 30 year follow-up of the Swedish Knee Arthroplasty Register. Eur J Cancer. 2011; 47: 1061-1071
-
(2011)
Eur J Cancer
, vol.47
, pp. 1061-1071
-
-
Wagner, P.1
Olsson, H.2
Lidgren, L.3
Robertsson, O.4
Ranstam, J.5
-
13
-
-
79960709287
-
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes
-
Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 2011; 29: 2897-2903
-
(2011)
J Clin Oncol
, vol.29
, pp. 2897-2903
-
-
Kristinsson, S.Y.1
Bjorkholm, M.2
Hultcrantz, M.3
Derolf, A.R.4
Landgren, O.5
Goldin, L.R.6
-
14
-
-
0035865012
-
Cancer risk in patients with inflammatory bowel disease: A population-based study
-
Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001; 91: 854-862
-
(2001)
Cancer
, vol.91
, pp. 854-862
-
-
Bernstein, C.N.1
Blanchard, J.F.2
Kliewer, E.3
Wajda, A.4
-
15
-
-
17644386242
-
Risk of haematopoietic cancer in patients with inflammatory bowel disease
-
Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005; 54: 617-622
-
(2005)
Gut
, vol.54
, pp. 617-622
-
-
Askling, J.1
Brandt, L.2
Lapidus, A.3
Karlen, P.4
Bjorkholm, M.5
Lofberg, R.6
-
16
-
-
84894287660
-
Community-Acquired infections and their association with myeloid malignancies
-
Titmarsh GJ, McMullin MF, McShane CM, Clarke M, Engels EA, Anderson LA. Community-Acquired infections and their association with myeloid malignancies. Cancer Epidemiol. 2014; 38: 56-61
-
(2014)
Cancer Epidemiol
, vol.38
, pp. 56-61
-
-
Titmarsh, G.J.1
McMullin, M.F.2
McShane, C.M.3
Clarke, M.4
Engels, E.A.5
Anderson, L.A.6
-
17
-
-
0030294026
-
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes
-
Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, et al. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 1996; 20: 891-900
-
(1996)
Leuk Res
, vol.20
, pp. 891-900
-
-
Shetty, V.1
Mundle, S.2
Alvi, S.3
Showel, M.4
Broady-Robinson, L.5
Dar, S.6
-
18
-
-
0033389116
-
Measurement of MRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes
-
Allampallam K, Shetty V, Hussaini S, Mazzoran L, Zorat F, Huang R, et al. Measurement of MRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes. Anticancer Res. 1999; 19: 5323-5328
-
(1999)
Anticancer Res
, vol.19
, pp. 5323-5328
-
-
Allampallam, K.1
Shetty, V.2
Hussaini, S.3
Mazzoran, L.4
Zorat, F.5
Huang, R.6
-
19
-
-
0031464758
-
Overexpression of tumor necrosis factor (TNF)-Alpha and interferon (ifn)-gamma by bone marrow cells from patients with myelodysplastic syndromes
-
Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, et al. Overexpression of tumor necrosis factor (TNF)-Alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia. 1997; 11: 2049-2054
-
(1997)
Leukemia
, vol.11
, pp. 2049-2054
-
-
Kitagawa, M.1
Saito, I.2
Kuwata, T.3
Yoshida, S.4
Yamaguchi, S.5
Takahashi, M.6
-
20
-
-
0034022396
-
Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome
-
Deeg HJ, Beckham C, Loken MR, Bryant E, Lesnikova M, Shulman HM, et al. Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome. Leuk Lymphoma. 2000; 37: 405-414
-
(2000)
Leuk Lymphoma
, vol.37
, pp. 405-414
-
-
Deeg, H.J.1
Beckham, C.2
Loken, M.R.3
Bryant, E.4
Lesnikova, M.5
Shulman, H.M.6
-
21
-
-
0036236034
-
In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome
-
Flores-Figueroa E, Gutierrez-Espindola G, Montesinos JJ, Arana-Trejo RM, Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res. 2002; 26: 677-686
-
(2002)
Leuk Res
, vol.26
, pp. 677-686
-
-
Flores-Figueroa, E.1
Gutierrez-Espindola, G.2
Montesinos, J.J.3
Arana-Trejo, R.M.4
Mayani, H.5
-
22
-
-
0031656518
-
A role for tumour necrosis factor-Alpha, fas and fas-ligand in marrow failure associated with myelodysplastic syndrome
-
Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, et al. A role for tumour necrosis factor-Alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol. 1998; 103: 176-188
-
(1998)
Br J Haematol
, vol.103
, pp. 176-188
-
-
Gersuk, G.M.1
Beckham, C.2
Loken, M.R.3
Kiener, P.4
Anderson, J.E.5
Farrand, A.6
-
23
-
-
0037411227
-
Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes
-
Sawanobori M, Yamaguchi S, Hasegawa M, Inoue M, Suzuki K, Kamiyama R, et al. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leuk Res. 2003; 27: 583-591
-
(2003)
Leuk Res
, vol.27
, pp. 583-591
-
-
Sawanobori, M.1
Yamaguchi, S.2
Hasegawa, M.3
Inoue, M.4
Suzuki, K.5
Kamiyama, R.6
-
24
-
-
0036369821
-
Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome
-
Hsu HC, Lee YM, Tsai WH, Jiang ML, Ho CH, Ho CK, et al. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology. 2002; 63: 64-69
-
(2002)
Oncology
, vol.63
, pp. 64-69
-
-
Hsu, H.C.1
Lee, Y.M.2
Tsai, W.H.3
Jiang, M.L.4
Ho, C.H.5
Ho, C.K.6
-
25
-
-
0026588363
-
In situ localization of transforming growth factor beta and s-phase cells in patients with acute myeloid leukemia and myelodysplastic syndrome
-
Qadir K, Bokhari SA, Miller MA, Siegrist C, Bismayer J, Raza A. In situ localization of transforming growth factor beta and S-phase cells in patients with acute myeloid leukemia and myelodysplastic syndrome. Anticancer Res. 1992; 12: 403-407
-
(1992)
Anticancer Res
, vol.12
, pp. 403-407
-
-
Qadir, K.1
Bokhari, S.A.2
Miller, M.A.3
Siegrist, C.4
Bismayer, J.5
Raza, A.6
-
26
-
-
0036170140
-
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia
-
Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res. 2002; 11: 119-125
-
(2002)
J Hematother Stem Cell Res
, vol.11
, pp. 119-125
-
-
Brunner, B.1
Gunsilius, E.2
Schumacher, P.3
Zwierzina, H.4
Gastl, G.5
Stauder, R.6
-
27
-
-
0037085781
-
Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia
-
Verstovsek S, Kantarjian H, Manshouri T, Cortes J, Giles FJ, Rogers A, et al. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood. 2002; 99: 2265-2267
-
(2002)
Blood
, vol.99
, pp. 2265-2267
-
-
Verstovsek, S.1
Kantarjian, H.2
Manshouri, T.3
Cortes, J.4
Giles, F.J.5
Rogers, A.6
-
28
-
-
84866113642
-
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes
-
Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, et al. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer. 2008; 113: 1605-1613
-
(2008)
Cancer
, vol.113
, pp. 1605-1613
-
-
Tsimberidou, A.M.1
Estey, E.2
Wen, S.3
Pierce, S.4
Kantarjian, H.5
Albitar, M.6
-
29
-
-
21344472917
-
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
-
Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005; 104: 788-793
-
(2005)
Cancer
, vol.104
, pp. 788-793
-
-
Meyers, C.A.1
Albitar, M.2
Estey, E.3
-
30
-
-
78549250108
-
Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia
-
Kornblau SM, McCue D, Singh N, Chen W, Estrov Z, Coombes KR. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010; 116: 4251-4261
-
(2010)
Blood
, vol.116
, pp. 4251-4261
-
-
Kornblau, S.M.1
McCue, D.2
Singh, N.3
Chen, W.4
Estrov, Z.5
Coombes, K.R.6
-
31
-
-
79953891819
-
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
-
Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, et al. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 2011; 96: 602-606
-
(2011)
Haematologica
, vol.96
, pp. 602-606
-
-
Feng, X.1
Scheinberg, P.2
Wu, C.O.3
Samsel, L.4
Nunez, O.5
Prince, C.6
-
32
-
-
84859632009
-
Ipss-independent prognostic value of plasma cxcl10 il-7 and il-6 levels in myelodysplastic syndromes
-
Pardanani A, Finke C, Lasho TL, Al-Kali A, Begna KH, Hanson CA, et al. IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes. Leukemia. 2012; 26: 693-699
-
(2012)
Leukemia
, vol.26
, pp. 693-699
-
-
Pardanani, A.1
Finke, C.2
Lasho, T.L.3
Al-Kali, A.4
Begna, K.H.5
Hanson, C.A.6
-
33
-
-
61849168098
-
Il-17-producing cd4(+) t cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
-
Kordasti SY, Afzali B, Lim Z, Ingram W, Hayden J, Barber L, et al. IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. Br J Haematol. 2009; 145: 64-72
-
(2009)
Br J Haematol
, vol.145
, pp. 64-72
-
-
Kordasti, S.Y.1
Afzali, B.2
Lim, Z.3
Ingram, W.4
Hayden, J.5
Barber, L.6
-
34
-
-
84875881003
-
Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification
-
Berthon C, Fontenay M, Corm S, Briche I, Allorge D, Hennart B, et al. Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification. Leuk Res. 2013; 37: 573-579
-
(2013)
Leuk Res
, vol.37
, pp. 573-579
-
-
Berthon, C.1
Fontenay, M.2
Corm, S.3
Briche, I.4
Allorge, D.5
Hennart, B.6
-
35
-
-
0028930939
-
Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis
-
Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, et al. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol. 1995; 48: 143-154
-
(1995)
Am J Hematol
, vol.48
, pp. 143-154
-
-
Raza, A.1
Mundle, S.2
Iftikhar, A.3
Gregory, S.4
Marcus, B.5
Khan, Z.6
-
36
-
-
0030926080
-
Fas/apo-1 (cd95) expression and apoptosis in patients with myelodysplastic syndromes
-
Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, et al. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia. 1997; 11: 839-845
-
(1997)
Leukemia
, vol.11
, pp. 839-845
-
-
Bouscary, D.1
De Vos, J.2
Guesnu, M.3
Jondeau, K.4
Viguier, F.5
Melle, J.6
-
37
-
-
0032945317
-
Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with fab subtype and anemia, and predicts survival
-
Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C, et al. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival. Leukemia. 1999; 13: 44-53
-
(1999)
Leukemia
, vol.13
, pp. 44-53
-
-
Gupta, P.1
Niehans, G.A.2
Leroy, S.C.3
Gupta, K.4
Morrison, V.A.5
Schultz, C.6
-
38
-
-
0029016931
-
Fas antigen expression on cd34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro
-
Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995; 85: 3183-3190
-
(1995)
Blood
, vol.85
, pp. 3183-3190
-
-
MacIejewski, J.1
Selleri, C.2
Anderson, S.3
Young, N.S.4
-
39
-
-
30144446015
-
Interferongamma-induced gene expression in cd34 cells: Identification of pathologic cytokine-specific signature profiles
-
Zeng W, Miyazato A, Chen G, Kajigaya S, Young NS, Maciejewski JP. Interferongamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood. 2006; 107: 167-175
-
(2006)
Blood
, vol.107
, pp. 167-175
-
-
Zeng, W.1
Miyazato, A.2
Chen, G.3
Kajigaya, S.4
Young, N.S.5
MacIejewski, J.P.6
-
40
-
-
85047692516
-
Signalling pathways of the TNF superfamily: A double-edged sword
-
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003; 3: 745-756
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 745-756
-
-
Aggarwal, B.B.1
-
41
-
-
28444479122
-
Nf-kappab and flip in arsenic trioxide (ato)-induced apoptosis in myelodysplastic syndromes (MDSS
-
Kerbauy DM, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). Blood. 2005; 106: 3917-3925
-
(2005)
Blood
, vol.106
, pp. 3917-3925
-
-
Kerbauy, D.M.1
Lesnikov, V.2
Abbasi, N.3
Seal, S.4
Scott, B.5
Deeg, H.J.6
-
42
-
-
77950943405
-
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
-
Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 2010; 24: 756-764
-
(2010)
Leukemia
, vol.24
, pp. 756-764
-
-
Pellagatti, A.1
Cazzola, M.2
Giagounidis, A.3
Perry, J.4
Malcovati, L.5
Della Porta, M.G.6
-
43
-
-
0036232326
-
Signaling via the interferon-Alpha receptor in chronic myelogenous leukemia cells
-
Verma A, Platanias LC. Signaling via the interferon-Alpha receptor in chronic myelogenous leukemia cells. Leuk Lymphoma. 2002; 43: 703-709
-
(2002)
Leuk Lymphoma
, vol.43
, pp. 703-709
-
-
Verma, A.1
Platanias, L.C.2
-
44
-
-
55049116044
-
Inhibition of p38alpha mapk disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment
-
Navas T, Zhou L, Estes M, Haghnazari E, Nguyen AN, Mo Y, et al. Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment. Leuk Lymphoma. 2008; 49: 1963-1975
-
(2008)
Leuk Lymphoma
, vol.49
, pp. 1963-1975
-
-
Navas, T.1
Zhou, L.2
Estes, M.3
Haghnazari, E.4
Nguyen, A.N.5
Mo, Y.6
-
45
-
-
77950343791
-
Pattern recognition receptors and inflammation
-
Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010; 140: 805-820
-
(2010)
Cell
, vol.140
, pp. 805-820
-
-
Takeuchi, O.1
Akira, S.2
-
46
-
-
84877577557
-
Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
-
Li J, Wang X, Zhang F, Yin H. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol Ther. 2013; 138: 441-451
-
(2013)
Pharmacol Ther
, vol.138
, pp. 441-451
-
-
Li, J.1
Wang, X.2
Zhang, F.3
Yin, H.4
-
47
-
-
33744978765
-
Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment
-
Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity. 2006; 24: 801-812
-
(2006)
Immunity
, vol.24
, pp. 801-812
-
-
Nagai, Y.1
Garrett, K.P.2
Ohta, S.3
Bahrun, U.4
Kouro, T.5
Akira, S.6
-
48
-
-
84856709581
-
Deregulation of micrornas in myelodysplastic syndrome
-
Rhyasen GW, Starczynowski DT. Deregulation of microRNAs in myelodysplastic syndrome. Leukemia. 2012; 26: 13-22
-
(2012)
Leukemia
, vol.26
, pp. 13-22
-
-
Rhyasen, G.W.1
Starczynowski, D.T.2
-
49
-
-
33947255107
-
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes
-
Maratheftis CI, Andreakos E, Moutsopoulos HM, Voulgarelis M. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res. 2007; 13: 1154-1160
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1154-1160
-
-
Maratheftis, C.I.1
Andreakos, E.2
Moutsopoulos, H.M.3
Voulgarelis, M.4
-
50
-
-
77950629227
-
Expression of toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia
-
Kuninaka N, Kurata M, Yamamoto K, Suzuki S, Umeda S, Kirimura S, et al. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia. Exp Mol Pathol. 2010; 88: 293-298
-
(2010)
Exp Mol Pathol
, vol.88
, pp. 293-298
-
-
Kuninaka, N.1
Kurata, M.2
Yamamoto, K.3
Suzuki, S.4
Umeda, S.5
Kirimura, S.6
-
51
-
-
84883742414
-
Toll-like receptor alterations in myelodysplastic syndrome
-
Wei Y, Dimicoli S, Bueso-Ramos C, Chen R, Yang H, Neuberg D, et al. Toll-like receptor alterations in myelodysplastic syndrome. Leukemia. 2013; 27: 1832-1840
-
(2013)
Leukemia
, vol.27
, pp. 1832-1840
-
-
Wei, Y.1
Dimicoli, S.2
Bueso-Ramos, C.3
Chen, R.4
Yang, H.5
Neuberg, D.6
-
52
-
-
84880982508
-
Impaired clearance of apoptotic cells leads to hmgb1 release in the bone marrow of patients with myelodysplastic syndromes and induces tlr4-mediated cytokine production
-
Velegraki M, Papakonstanti E, Mavroudi I, Psyllaki M, Tsatsanis C, Oulas A, et al. Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production. Haematologica. 2013; 98: 1206-1215
-
(2013)
Haematologica
, vol.98
, pp. 1206-1215
-
-
Velegraki, M.1
Papakonstanti, E.2
Mavroudi, I.3
Psyllaki, M.4
Tsatsanis, C.5
Oulas, A.6
-
53
-
-
0037111773
-
Characterization of gene expression of cd34+ cells from normal and myelodysplastic bone marrow
-
Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood. 2002; 100: 3553-3560
-
(2002)
Blood
, vol.100
, pp. 3553-3560
-
-
Hofmann, W.K.1
De Vos, S.2
Komor, M.3
Hoelzer, D.4
Wachsman, W.5
Koeffler, H.P.6
-
54
-
-
54049105351
-
High-resolution whole genome tiling path array cgh analysis of cd34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
-
Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K, Brooks-Wilson A, et al. High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood. 2008; 112: 3412-3424
-
(2008)
Blood
, vol.112
, pp. 3412-3424
-
-
Starczynowski, D.T.1
Vercauteren, S.2
Telenius, A.3
Sung, S.4
Tohyama, K.5
Brooks-Wilson, A.6
-
55
-
-
38949123096
-
Chromosomal lesions and uniparental disomy detected by snp arrays in MDS MDS/MPD and MDS-derived AML
-
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood. 2008; 111: 1534-1542
-
(2008)
Blood
, vol.111
, pp. 1534-1542
-
-
Gondek, L.P.1
Tiu, R.2
O'Keefe, C.L.3
Sekeres, M.A.4
Theil, K.S.5
MacIejewski, J.P.6
-
56
-
-
84881600082
-
Overexpression of the toll-like receptor (tlr) signaling adaptor myd88, but lack of genetic mutation, in myelodysplastic syndromes
-
Dimicoli S, Wei Y, Bueso-Ramos C, Yang H, Dinardo C, Jia Y, et al. Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes. PLoS One. 2013; 8: e71120
-
(2013)
PLoS One
, vol.8
, pp. e71120
-
-
Dimicoli, S.1
Wei, Y.2
Bueso-Ramos, C.3
Yang, H.4
Dinardo, C.5
Jia, Y.6
-
57
-
-
84880002232
-
Targeting irak1 as a therapeutic approach for myelodysplastic syndrome
-
Rhyasen GW, Bolanos L, Fang J, Jerez A, Wunderlich M, Rigolino C, et al. Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome. Cancer Cell. 2013; 24: 90-104
-
(2013)
Cancer Cell
, vol.24
, pp. 90-104
-
-
Rhyasen, G.W.1
Bolanos, L.2
Fang, J.3
Jerez, A.4
Wunderlich, M.5
Rigolino, C.6
-
58
-
-
84887322071
-
Global h3k4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of jmjd3 in human myelodysplastic syndrome cd34+ cells
-
Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia. 2013; 27: 2177-2186
-
(2013)
Leukemia
, vol.27
, pp. 2177-2186
-
-
Wei, Y.1
Chen, R.2
Dimicoli, S.3
Bueso-Ramos, C.4
Neuberg, D.5
Pierce, S.6
-
59
-
-
84888876950
-
Differential irak signaling in hematologic malignancies
-
Rhyasen GW, Bolanos L, Starczynowski DT. Differential IRAK signaling in hematologic malignancies. Exp Hematol. 2013; 41: 1005-1007
-
(2013)
Exp Hematol
, vol.41
, pp. 1005-1007
-
-
Rhyasen, G.W.1
Bolanos, L.2
Starczynowski, D.T.3
-
60
-
-
84865183566
-
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
-
Barreyro L, Will B, Bartholdy B, Zhou L, Todorova TI, Stanley RF, et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood. 2012; 120: 1290-1298
-
(2012)
Blood
, vol.120
, pp. 1290-1298
-
-
Barreyro, L.1
Will, B.2
Bartholdy, B.3
Zhou, L.4
Todorova, T.I.5
Stanley, R.F.6
-
61
-
-
73849121794
-
Identification of mir-145 and mir-146a as mediators of the 5q- syndrome phenotype
-
Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med. 2010; 16: 49-58
-
(2010)
Nat Med
, vol.16
, pp. 49-58
-
-
Starczynowski, D.T.1
Kuchenbauer, F.2
Argiropoulos, B.3
Sung, S.4
Morin, R.5
Muranyi, A.6
-
62
-
-
84155172567
-
Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells
-
Boiko JR, Borghesi L. Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine. 2012; 57: 1-8
-
(2012)
Cytokine
, vol.57
, pp. 1-8
-
-
Boiko, J.R.1
Borghesi, L.2
-
63
-
-
33751315780
-
Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow cd34+ progenitor cells along the myeloid lineage
-
Sioud M, Floisand Y, Forfang L, Lund-Johansen F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J Mol Biol. 2006; 364: 945-954
-
(2006)
J Mol Biol
, vol.364
, pp. 945-954
-
-
Sioud, M.1
Floisand, Y.2
Forfang, L.3
Lund-Johansen, F.4
-
64
-
-
70450237721
-
The tlr1/2 agonist pam(3)csk(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate
-
De Luca K, Frances-Duvert V, Asensio MJ, Ihsani R, Debien E, Taillardet M, et al. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia. 2009; 23: 2063-2074
-
(2009)
Leukemia
, vol.23
, pp. 2063-2074
-
-
De Luca, K.1
Frances-Duvert, V.2
Asensio, M.J.3
Ihsani, R.4
Debien, E.5
Taillardet, M.6
-
65
-
-
84892163011
-
Myd88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen
-
Fiedler K, Kokai E, Bresch S, Brunner C. MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen. Am J Blood Res. 2013; 3: 124-140
-
(2013)
Am J Blood Res
, vol.3
, pp. 124-140
-
-
Fiedler, K.1
Kokai, E.2
Bresch, S.3
Brunner, C.4
-
66
-
-
79955530513
-
Chronic exposure to a tlr ligand injures hematopoietic stem cells
-
Esplin BL, Shimazu T, Welner RS, Garrett KP, Nie L, Zhang Q, et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol. 2011; 186: 5367-5375
-
(2011)
J Immunol
, vol.186
, pp. 5367-5375
-
-
Esplin, B.L.1
Shimazu, T.2
Welner, R.S.3
Garrett, K.P.4
Nie, L.5
Zhang, Q.6
-
67
-
-
70349661920
-
5q- myelodysplastic syndromes: Chromosome 5q genes direct a tumorsuppression network sensing actin dynamics
-
Eisenmann KM, Dykema KJ, Matheson SF, Kent NF, DeWard AD, West RA, et al. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumorsuppression network sensing actin dynamics. Oncogene. 2009; 28: 3429-3441
-
(2009)
Oncogene
, vol.28
, pp. 3429-3441
-
-
Eisenmann, K.M.1
Dykema, K.J.2
Matheson, S.F.3
Kent, N.F.4
Deward, A.D.5
West, R.A.6
-
68
-
-
84905082105
-
Aberrant overexpression of cd14 on granulocytes sensitizes the innate immune response in mdia1 heterozygous del(5q) MDS
-
Keerthivasan G, Mei Y, Zhao B, Zhang L, Harris CE, Gao J, et al. Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS. Blood. 2014; 124: 780-790
-
(2014)
Blood
, vol.124
, pp. 780-790
-
-
Keerthivasan, G.1
Mei, Y.2
Zhao, B.3
Zhang, L.4
Harris, C.E.5
Gao, J.6
-
69
-
-
33645971047
-
Good cop, bad cop: The different faces of nf-kappab
-
Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Diff. 2006; 13: 759-772
-
(2006)
Cell Death Diff
, vol.13
, pp. 759-772
-
-
Perkins, N.D.1
Gilmore, T.D.2
-
70
-
-
0033562798
-
An essential role for nf-kappab in human cd34(+) bone marrow cell survival
-
Pyatt DW, Stillman WS, Yang Y, Gross S, Zheng JH, Irons RD. An essential role for NF-kappaB in human CD34(+) bone marrow cell survival. Blood. 1999; 93: 3302-3308
-
(1999)
Blood
, vol.93
, pp. 3302-3308
-
-
Pyatt, D.W.1
Stillman, W.S.2
Yang, Y.3
Gross, S.4
Zheng, J.H.5
Irons, R.D.6
-
71
-
-
31544448567
-
Nfkappab constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
-
Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F, et al. NFkappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006; 107: 1156-1165
-
(2006)
Blood
, vol.107
, pp. 1156-1165
-
-
Braun, T.1
Carvalho, G.2
Coquelle, A.3
Vozenin, M.C.4
Lepelley, P.5
Hirsch, F.6
-
72
-
-
34250333058
-
Nf-kappab inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia
-
Fabre C, Carvalho G, Tasdemir E, Braun T, Ades L, Grosjean J, et al. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene. 2007; 26: 4071-4083
-
(2007)
Oncogene
, vol.26
, pp. 4071-4083
-
-
Fabre, C.1
Carvalho, G.2
Tasdemir, E.3
Braun, T.4
Ades, L.5
Grosjean, J.6
-
73
-
-
84882436729
-
Deletion of the nf-kappab subunit p65/rela in the hematopoietic compartment leads to defects in hematopoietic stem cell function
-
Stein SJ, Baldwin AS. Deletion of the NF-kappaB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function. Blood. 2013; 121: 5015-5024
-
(2013)
Blood
, vol.121
, pp. 5015-5024
-
-
Stein, S.J.1
Baldwin, A.S.2
-
74
-
-
84859503920
-
Noncanonical nf-kappab signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions
-
Zhao C, Xiu Y, Ashton J, Xing L, Morita Y, Jordan CT, et al. Noncanonical NF-kappaB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions. Stem Cells. 2012; 30: 709-718
-
(2012)
Stem Cells
, vol.30
, pp. 709-718
-
-
Zhao, C.1
Xiu, Y.2
Ashton, J.3
Xing, L.4
Morita, Y.5
Jordan, C.T.6
-
75
-
-
33845954687
-
Constitutive activation of nf-kappa b is not sufficient to disturb normal steady-state hematopoiesis
-
Schepers H, Eggen BJ, Schuringa JJ, Vellenga E. Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis. Haematologica. 2006; 91: 1710-1711
-
(2006)
Haematologica
, vol.91
, pp. 1710-1711
-
-
Schepers, H.1
Eggen, B.J.2
Schuringa, J.J.3
Vellenga, E.4
-
76
-
-
20244364979
-
Stromamediated dysregulation of myelopoiesis in mice lacking i kappa b alpha
-
Rupec RA, Jundt F, Rebholz B, Eckelt B, Weindl G, Herzinger T, et al. Stromamediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity. 2005; 22: 479-491
-
(2005)
Immunity
, vol.22
, pp. 479-491
-
-
Rupec, R.A.1
Jundt, F.2
Rebholz, B.3
Eckelt, B.4
Weindl, G.5
Herzinger, T.6
-
77
-
-
0026672334
-
Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus
-
Hawley RG, Fong AZ, Burns BF, Hawley TS. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med. 1992; 176: 1149-1163
-
(1992)
J Exp Med
, vol.176
, pp. 1149-1163
-
-
Hawley, R.G.1
Fong, A.Z.2
Burns, B.F.3
Hawley, T.S.4
-
78
-
-
22544451527
-
Multiple members of the TNF superfamily contribute to ifn-gamma-mediated inhibition of erythropoiesis
-
Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, Conticello C, et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol. 2005; 175: 1464-1472
-
(2005)
J Immunol
, vol.175
, pp. 1464-1472
-
-
Felli, N.1
Pedini, F.2
Zeuner, A.3
Petrucci, E.4
Testa, U.5
Conticello, C.6
-
79
-
-
11844299080
-
Ifn-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells
-
Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, et al. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol. 2005; 174: 752-757
-
(2005)
J Immunol
, vol.174
, pp. 752-757
-
-
Yang, L.1
Dybedal, I.2
Bryder, D.3
Nilsson, L.4
Sitnicka, E.5
Sasaki, Y.6
-
80
-
-
1642513702
-
Stimulation of human toll-like receptor (tlr) 2 and tlr6 with membrane lipoproteins of mycoplasma fermentans induces apoptotic cell death after nf-kappa b activation
-
Into T, Kiura K, Yasuda M, Kataoka H, Inoue N, Hasebe A, et al. Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol. 2004; 6: 187-199
-
(2004)
Cell Microbiol
, vol.6
, pp. 187-199
-
-
Into, T.1
Kiura, K.2
Yasuda, M.3
Kataoka, H.4
Inoue, N.5
Hasebe, A.6
-
81
-
-
0034601057
-
The apoptotic signaling pathway activated by toll-like receptor-2
-
Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 2000; 19: 3325-3336
-
(2000)
EMBO J
, vol.19
, pp. 3325-3336
-
-
Aliprantis, A.O.1
Yang, R.B.2
Weiss, D.S.3
Godowski, P.4
Zychlinsky, A.5
-
82
-
-
0033515827
-
Multilineage potential of adult human mesenchymal stem cells
-
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147
-
(1999)
Science
, vol.284
, pp. 143-147
-
-
Pittenger, M.F.1
MacKay, A.M.2
Beck, S.C.3
Jaiswal, R.K.4
Douglas, R.5
Mosca, J.D.6
-
83
-
-
18544371666
-
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
-
Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005; 105: 4120-4126
-
(2005)
Blood
, vol.105
, pp. 4120-4126
-
-
Jiang, X.X.1
Zhang, Y.2
Liu, B.3
Zhang, S.X.4
Wu, Y.5
Yu, X.D.6
-
84
-
-
43049156408
-
Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells
-
Flores-Figueroa E, Montesinos JJ, Flores-Guzman P, Gutierrez-Espindola G, Arana-Trejo RM, Castillo-Medina S, et al. Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leuk Res. 2008; 32: 1407-1416
-
(2008)
Leuk Res
, vol.32
, pp. 1407-1416
-
-
Flores-Figueroa, E.1
Montesinos, J.J.2
Flores-Guzman, P.3
Gutierrez-Espindola, G.4
Arana-Trejo, R.M.5
Castillo-Medina, S.6
-
85
-
-
77954928083
-
Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes
-
Klaus M, Stavroulaki E, Kastrinaki MC, Fragioudaki P, Giannikou K, Psyllaki M, et al. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev. 2010; 19: 1043-1054
-
(2010)
Stem Cells Dev
, vol.19
, pp. 1043-1054
-
-
Klaus, M.1
Stavroulaki, E.2
Kastrinaki, M.C.3
Fragioudaki, P.4
Giannikou, K.5
Psyllaki, M.6
-
86
-
-
84874639295
-
The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes
-
Wang Z, Tang X, Xu W, Cao Z, Sun L, Li W, et al. The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes. PLoS One. 2013; 8: e57470
-
(2013)
PLoS One
, vol.8
, pp. e57470
-
-
Wang, Z.1
Tang, X.2
Xu, W.3
Cao, Z.4
Sun, L.5
Li, W.6
-
87
-
-
84902200836
-
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit
-
Medyouf H, Mossner M, Jann JC, Nolte F, Raffel S, Herrmann C, et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 2014; 14: 824-837
-
(2014)
Cell Stem Cell
, vol.14
, pp. 824-837
-
-
Medyouf, H.1
Mossner, M.2
Jann, J.C.3
Nolte, F.4
Raffel, S.5
Herrmann, C.6
-
88
-
-
0031979845
-
Localization of fas and fas ligand in bone marrow cells demonstrating myelodysplasia
-
Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. Leukemia. 1998; 12: 486-492
-
(1998)
Leukemia
, vol.12
, pp. 486-492
-
-
Kitagawa, M.1
Yamaguchi, S.2
Takahashi, M.3
Tanizawa, T.4
Hirokawa, K.5
Kamiyama, R.6
-
89
-
-
38349113450
-
Tumour necrosis factor-induced gene expression in human marrow stroma clues to the pathophysiology of MDS?
-
Stirewalt DL, Mhyre AJ, Marcondes M, Pogosova-Agadjanyan E, Abbasi N, Radich JP, et al. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?. Br J Haematol. 2008; 140: 444-453
-
(2008)
Br J Haematol
, vol.140
, pp. 444-453
-
-
Stirewalt, D.L.1
Mhyre, A.J.2
Marcondes, M.3
Pogosova-Agadjanyan, E.4
Abbasi, N.5
Radich, J.P.6
-
90
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009; 9: 162-174
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
91
-
-
84887430236
-
Induction of myelodysplasia by myeloid-derived suppressor cells
-
Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, et al. Induction of myelodysplasia by myeloid-derived suppressor cells. J Clin Invest. 2013; 123: 4595-4611
-
(2013)
J Clin Invest
, vol.123
, pp. 4595-4611
-
-
Chen, X.1
Eksioglu, E.A.2
Zhou, J.3
Zhang, L.4
Djeu, J.5
Fortenbery, N.6
-
92
-
-
34948900275
-
Mrp8 and mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock
-
Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007; 13: 1042-1049
-
(2007)
Nat Med
, vol.13
, pp. 1042-1049
-
-
Vogl, T.1
Tenbrock, K.2
Ludwig, S.3
Leukert, N.4
Ehrhardt, C.5
Van Zoelen, M.A.6
-
93
-
-
79951812916
-
Telomere dysfunction induces metabolic and mitochondrial compromise
-
Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011; 470: 359-365
-
(2011)
Nature
, vol.470
, pp. 359-365
-
-
Sahin, E.1
Colla, S.2
Liesa, M.3
Moslehi, J.4
Muller, F.L.5
Guo, M.6
-
94
-
-
77956920766
-
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells
-
Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010; 185: 2273-2284
-
(2010)
J Immunol
, vol.185
, pp. 2273-2284
-
-
Lechner, M.G.1
Liebertz, D.J.2
Epstein, A.L.3
-
95
-
-
84874235360
-
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
-
Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, et al. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci USA. 2013; 110: 3011-3016
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. 3011-3016
-
-
Pang, W.W.1
Pluvinage, J.V.2
Price, E.A.3
Sridhar, K.4
Arber, D.A.5
Greenberg, P.L.6
-
96
-
-
67650065350
-
Patients with myelodysplastic syndromes display several t-cell expansions, which are mostly polyclonal in the cd4(+) subset and oligoclonal in the cd8(+) subset
-
Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, et al. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Exp Hematol. 2009; 37: 947-955
-
(2009)
Exp Hematol
, vol.37
, pp. 947-955
-
-
Fozza, C.1
Contini, S.2
Galleu, A.3
Simula, M.P.4
Virdis, P.5
Bonfigli, S.6
-
97
-
-
62549141807
-
Kinetics, function and bone marrow trafficking of cd4+cd25+foxp3+ regulatory t cells in myelodysplastic syndromes (MDS
-
Kotsianidis I, Bouchliou I, Nakou E, Spanoudakis E, Margaritis D, Christophoridou AV, et al. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia. 2009; 23: 510-518
-
(2009)
Leukemia
, vol.23
, pp. 510-518
-
-
Kotsianidis, I.1
Bouchliou, I.2
Nakou, E.3
Spanoudakis, E.4
Margaritis, D.5
Christophoridou, A.V.6
-
98
-
-
84875906562
-
Il10 inversely correlates with the percentage of cd8(+) cells in MDS patients
-
Lopes MR, Traina F, Campos Pde M, Pereira JK, Machado-Neto JA, Machado Hda C, et al. IL10 inversely correlates with the percentage of CD8(+) cells in MDS patients. Leuk Res. 2013; 37: 541-546
-
(2013)
Leuk Res
, vol.37
, pp. 541-546
-
-
Lopes, M.R.1
Traina, F.2
Campos Pde, M.3
Pereira, J.K.4
MacHado-Neto, J.A.5
MacHado Hda, C.6
-
99
-
-
79953100658
-
T-cell immune responses to wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy
-
Sloand EM, Melenhorst JJ, Tucker ZC, Pfannes L, Brenchley JM, Yong A, et al. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy. Blood. 2011; 117: 2691-2699
-
(2011)
Blood
, vol.117
, pp. 2691-2699
-
-
Sloand, E.M.1
Melenhorst, J.J.2
Tucker, Z.C.3
Pfannes, L.4
Brenchley, J.M.5
Yong, A.6
-
100
-
-
18744412931
-
Autologous lymphocytes inhibit hemopoiesis in long-Term culture in patients with myelodysplastic syndrome
-
Baumann I, Scheid C, Koref MS, Swindell R, Stern P, Testa NG. Autologous lymphocytes inhibit hemopoiesis in long-Term culture in patients with myelodysplastic syndrome. Exp Hematol. 2002; 30: 1405-1411
-
(2002)
Exp Hematol
, vol.30
, pp. 1405-1411
-
-
Baumann, I.1
Scheid, C.2
Koref, M.S.3
Swindell, R.4
Stern, P.5
Testa, N.G.6
-
101
-
-
84876704647
-
Interleukin-17 enhances the production of interferon-gamma and tumour necrosis factor-Alpha by bone marrow t lymphocytes from patients with lower risk myelodysplastic syndromes
-
Zhang Z, Li X, Guo J, Xu F, He Q, Zhao Y, et al. Interleukin-17 enhances the production of interferon-gamma and tumour necrosis factor-Alpha by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes. Eur J Haematol. 2013; 90: 375-384
-
(2013)
Eur J Haematol
, vol.90
, pp. 375-384
-
-
Zhang, Z.1
Li, X.2
Guo, J.3
Xu, F.4
He, Q.5
Zhao, Y.6
-
102
-
-
77954536742
-
In vitro deprivation of cd8(+)cd57(+)t cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome
-
Zheng Z, Qianqiao Z, Qi H, Feng X, Chunkang C, Xiao L. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Exp Hematol. 2010; 38: 677-684
-
(2010)
Exp Hematol
, vol.38
, pp. 677-684
-
-
Zheng, Z.1
Qianqiao, Z.2
Qi, H.3
Feng, X.4
Chunkang, C.5
Xiao, L.6
-
103
-
-
34547957665
-
Cd4 +cd25high foxp3+ regulatory t cells in myelodysplastic syndrome (MDS
-
Kordasti SY, Ingram W, Hayden J, Darling D, Barber L, Afzali B, et al. CD4 +CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood. 2007; 110: 847-850
-
(2007)
Blood
, vol.110
, pp. 847-850
-
-
Kordasti, S.Y.1
Ingram, W.2
Hayden, J.3
Darling, D.4
Barber, L.5
Afzali, B.6
-
104
-
-
34249740754
-
ReduceDNAtural killer (nk) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating nk receptors
-
Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, et al. ReduceDNAtural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood. 2007; 109: 4816-4824
-
(2007)
Blood
, vol.109
, pp. 4816-4824
-
-
Epling-Burnette, P.K.1
Bai, F.2
Painter, J.S.3
Rollison, D.E.4
Salih, H.R.5
Krusch, M.6
-
105
-
-
84866152555
-
Expansion of effector memory regulatory t cells represents a novel prognostic factor in lower risk myelodysplastic syndrome
-
Mailloux AW, Sugimori C, Komrokji RS, Yang L, Maciejewski JP, Sekeres MA, et al. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol. 2012; 189: 3198-3208
-
(2012)
J Immunol
, vol.189
, pp. 3198-3208
-
-
Mailloux, A.W.1
Sugimori, C.2
Komrokji, R.S.3
Yang, L.4
MacIejewski, J.P.5
Sekeres, M.A.6
-
106
-
-
33644538600
-
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes
-
Kiladjian JJ, Bourgeois E, Lobe I, Braun T, Visentin G, Bourhis JH, et al. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia. 2006; 20: 463-470
-
(2006)
Leukemia
, vol.20
, pp. 463-470
-
-
Kiladjian, J.J.1
Bourgeois, E.2
Lobe, I.3
Braun, T.4
Visentin, G.5
Bourhis, J.H.6
-
107
-
-
0037376257
-
Determination of t-cell receptors of clonal cd8-positive t-cells in myelodysplastic syndrome with erythroid hypoplasia
-
Matsutani T, Yoshioka T, Tsuruta Y, Shimamoto T, Ohyashiki JH, Suzuki R, et al. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia. Leuk Res. 2003; 27: 305-312
-
(2003)
Leuk Res
, vol.27
, pp. 305-312
-
-
Matsutani, T.1
Yoshioka, T.2
Tsuruta, Y.3
Shimamoto, T.4
Ohyashiki, J.H.5
Suzuki, R.6
-
108
-
-
0034765667
-
Increased cytotoxic t cells with effector phenotype in aplastic anemia and myelodysplasia
-
Kook H, Zeng W, Guibin C, Kirby M, Young NS, Maciejewski JP. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp Hematol. 2001; 29: 1270-1277
-
(2001)
Exp Hematol
, vol.29
, pp. 1270-1277
-
-
Kook, H.1
Zeng, W.2
Guibin, C.3
Kirby, M.4
Young, N.S.5
MacIejewski, J.P.6
-
109
-
-
84902075577
-
Expression of pd-l1, pd-l2, pd-1 and ctla4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
-
Yang H, Bueso-Ramos C, DiNardo C, Estecio MR, Davanlou M, Geng QR, et al. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents. Leukemia. 2014; 28: 1280-1288
-
(2014)
Leukemia
, vol.28
, pp. 1280-1288
-
-
Yang, H.1
Bueso-Ramos, C.2
Dinardo, C.3
Estecio, M.R.4
Davanlou, M.5
Geng, Q.R.6
-
110
-
-
27644572272
-
Evidence for reduced b-cell progenitors in early (low-risk) myelodysplastic syndrome
-
Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, Seidl T, et al. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood. 2005; 106: 2982-2991
-
(2005)
Blood
, vol.106
, pp. 2982-2991
-
-
Sternberg, A.1
Killick, S.2
Littlewood, T.3
Hatton, C.4
Peniket, A.5
Seidl, T.6
-
111
-
-
40849127239
-
Activation of cytotoxic t-cell receptor gammadelta t lymphocytes in response to specific stimulation in myelodysplastic syndromes
-
Kiladjian JJ, Visentin G, Viey E, Chevret S, Eclache V, Stirnemann J, et al. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes. Haematologica. 2008; 93: 381-389
-
(2008)
Haematologica
, vol.93
, pp. 381-389
-
-
Kiladjian, J.J.1
Visentin, G.2
Viey, E.3
Chevret, S.4
Eclache, V.5
Stirnemann, J.6
-
113
-
-
84864495501
-
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of traf6 and repression of psma1
-
Fang J, Rhyasen G, Bolanos L, Rasch C, Varney M, Wunderlich M, et al. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1. Blood. 2012; 120: 858-867
-
(2012)
Blood
, vol.120
, pp. 858-867
-
-
Fang, J.1
Rhyasen, G.2
Bolanos, L.3
Rasch, C.4
Varney, M.5
Wunderlich, M.6
-
114
-
-
33845474265
-
Inhibition of overactivated p38 mapk can restore hematopoiesis in myelodysplastic syndrome progenitors
-
Navas TA, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, et al. Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood. 2006; 108: 4170-4177
-
(2006)
Blood
, vol.108
, pp. 4170-4177
-
-
Navas, T.A.1
Mohindru, M.2
Estes, M.3
Ma, J.Y.4
Sokol, L.5
Pahanish, P.6
-
115
-
-
84937024000
-
Inhibition of cxcr2 as a therapeutic strategy in AML and MDS [ash 2013 abstract 484
-
Schinke C, Giricz O, Gordon SAK, Barreyro L, Bhagat TD, Pellagatti A, et al. Inhibition of CXCR2 as a therapeutic strategy in AML and MDS [ASH 2013 Abstract 484]. Blood. 2013; 122: 484
-
(2013)
Blood
, vol.122
, pp. 484
-
-
Schinke, C.1
Giricz, O.2
Gordon, S.A.K.3
Barreyro, L.4
Bhagat, T.D.5
Pellagatti, A.6
-
116
-
-
85015970319
-
Phase i dose-escalation/expansion study of arry-614 in patients with ipss low/int-1 risk myelodysplastic syndromes [ash 2013 abstract 484
-
Garcia-Manero G, Sekeres MA, List AF, Khoury HJ, Advani A, Jabbour E, et al. Phase I dose-escalation/expansion study of ARRY-614 in patients with IPSS Low/Int-1 Risk Myelodysplastic Syndromes [ASH 2013 Abstract 484]. Blood. 2013; 122: 387
-
(2013)
Blood
, vol.122
, pp. 387
-
-
Garcia-Manero, G.1
Sekeres, M.A.2
List, A.F.3
Khoury, H.J.4
Advani, A.5
Jabbour, E.6
-
117
-
-
84886725015
-
Randomized, double-blind, placebo-controlled, dose-escalating phase i, healthy subjects study of intravenous opn-305, a humanized anti-Tlr2 antibody
-
Reilly M, Miller RM, Thomson MH, Patris V, Ryle P, McLoughlin L, et al. Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody. Clin Pharmacol Ther. 2013; 94: 593-600
-
(2013)
Clin Pharmacol Ther
, vol.94
, pp. 593-600
-
-
Reilly, M.1
Miller, R.M.2
Thomson, M.H.3
Patris, V.4
Ryle, P.5
McLoughlin, L.6
-
118
-
-
79551518231
-
Reduced smad7 leads to overactivation of tgf-beta signaling in MDS that can be reversed by a specific inhibitor of tgf-beta receptor i kinase
-
Zhou L, McMahon C, Bhagat T, Alencar C, Yu Y, Fazzari M, et al. Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. Cancer Res. 2011; 71: 955-963
-
(2011)
Cancer Res
, vol.71
, pp. 955-963
-
-
Zhou, L.1
McMahon, C.2
Bhagat, T.3
Alencar, C.4
Yu, Y.5
Fazzari, M.6
-
119
-
-
77951718214
-
Selective inhibition of ido1 effectively regulates mediators of antitumor immunity
-
Liu X, Shin N, Koblish HK, Yang G, Wang Q, Wang K, et al. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood. 2010; 115: 3520-3530
-
(2010)
Blood
, vol.115
, pp. 3520-3530
-
-
Liu, X.1
Shin, N.2
Koblish, H.K.3
Yang, G.4
Wang, Q.5
Wang, K.6
-
120
-
-
84898606191
-
Overexpression of mir-125a in myelodysplastic syndrome cd34+ cells modulates nf-kappab activation and enhances erythroid differentiation arrest
-
Ganan-Gomez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, et al. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-kappaB activation and enhances erythroid differentiation arrest. PLoS One. 2014; 9: e93404
-
(2014)
PLoS One
, vol.9
, pp. e93404
-
-
Ganan-Gomez, I.1
Wei, Y.2
Yang, H.3
Pierce, S.4
Bueso-Ramos, C.5
Calin, G.6
|